# CRACR2A

## Overview
CRACR2A is a gene that encodes the calcium release-activated channel regulator 2A, a multifunctional protein involved in calcium signaling and intracellular transport processes. This protein is characterized by its EF-hand domains, which are calcium-binding motifs, and a coiled-coil domain, enabling it to function as a calcium-activated dynein adaptor protein. CRACR2A plays a pivotal role in T cell activation by regulating store-operated calcium entry (SOCE) through its interaction with key components of the calcium release-activated calcium (CRAC) channel, such as STIM1 and Orai1. The protein exists in multiple isoforms, including a long variant with a Rab GTPase domain, which is involved in vesicle trafficking and intracellular signaling pathways. Mutations in the CRACR2A gene have been associated with various clinical conditions, including primary immunodeficiency disorders and other diseases, underscoring its importance in immune regulation and cellular function (Srikanth2010A; Wu2021Biallelic; Wang2019CRACR2a).

## Structure
CRACR2A is a protein that contains EF-hand domains, which are calcium-binding motifs, and a coiled-coil domain. These structural features are crucial for its function as a calcium-activated dynein adaptor protein involved in endocytic traffic in T cells (Wang2018A; Wang2019CRACR2a). The EF-hand domains allow CRACR2A to respond to changes in calcium levels, which is essential for its interaction with dynein and dynactin, facilitating microtubule-based transport (Wang2019CRACR2a). 

CRACR2A undergoes alternative splicing, resulting in different isoforms, including a long variant known as CRACR2A-L. This variant is expressed in endothelial cells and features a C-terminal Rab GTPase extension, distinguishing it from the shorter isoform (Wilson2015Expression). The long isoform, CRACR2A-L, is involved in endothelial tube formation, although it does not affect CRAC channels in these cells (Wilson2015Expression). 

The protein's structure also includes a Rab GTPase domain, which is fused into a single polypeptide with the EF-hand and coiled-coil domains, allowing it to function as a dynein-dynactin activator (Wang2019CRACR2a). The presence of these domains suggests a complex tertiary structure, although specific details on the primary, secondary, or quaternary structures are not provided in the available context.

## Function
The CRACR2A gene encodes a protein that plays a crucial role in calcium signaling pathways, particularly in T cells. It is involved in the regulation of store-operated calcium entry (SOCE) by interacting with key components of the calcium release-activated calcium (CRAC) channel, namely STIM1 and Orai1. CRACR2A acts as a cytosolic calcium sensor, stabilizing the CRAC channels and facilitating the clustering of Orai1 and STIM1 at the plasma membrane-endoplasmic reticulum junctions, which is essential for effective calcium signaling in T cells (Srikanth2010A).

CRACR2A exists in two isoforms, CRACR2A-a and CRACR2A-c, each with distinct roles. CRACR2A-a is a large Rab GTPase involved in vesicle trafficking and intracellular signaling, particularly in the activation of the Ca2+-NFAT and Jnk-AP1 signaling pathways. It is predominantly in a GTP-bound form in resting T cells and is recruited to the immunological synapse upon TCR stimulation, playing a role in T cell activation and cytokine production (Srikanth2016A; Srikanth2016Aa). CRACR2A-c, on the other hand, facilitates CRAC channel function by stabilizing the Orai1-STIM1 interaction (Srikanth2016A).

CRACR2A also functions as a calcium-activated dynein adaptor protein, regulating endocytic trafficking and intracellular transport processes, linking calcium signaling to dynein function (Wang2019CRACR2a).

## Clinical Significance
Mutations in the CRACR2A gene, also known as EFCAB4B, have been linked to several clinical conditions. Biallelic mutations in CRACR2A are associated with a primary immunodeficiency disorder characterized by recurrent infections, panhypogammaglobulinemia, and CD4+ T cell lymphopenia. These mutations impair T cell function by affecting calcium influx and signaling pathways, leading to reduced cytokine production and impaired T cell proliferation (Wu2021Biallelic). Specific mutations, such as E278D and R144G/E300*, disrupt store-operated calcium entry (SOCE) and JNK phosphorylation, crucial for T cell receptor signaling (Wu2021Biallelic).

CRACR2A has also been implicated in other diseases through genome-wide association studies. Variants in the gene have been associated with conditions like Parkinson's disease, nonalcoholic fatty liver disease, atrial fibrillation, and chronic HIV infection (Wu2021Biallelic). Additionally, genetic variants in CRACR2A have been linked to COVID-19 fatality. Missense mutations in the gene may alter protein function, contributing to the pro-thrombotic and pro-inflammatory responses observed in severe COVID-19 cases (Wang2022EFCAB4B). These findings highlight the gene's significant role in immune regulation and its potential impact on various diseases.

## Interactions
CRACR2A interacts with several proteins, playing a crucial role in T cell activation and calcium signaling. It forms a ternary complex with Orai1 and STIM1, essential for the clustering of these proteins upon store depletion, which is vital for the function of CRAC channels. This interaction is modulated by calcium levels, with elevated calcium causing the complex to dissociate (Srikanth2010A). CRACR2A also binds to the N terminus of Orai1 and the coiled-coil and proline/lysine-rich domains of STIM1, with these interactions being sensitive to calcium concentrations (Srikanth2010A).

CRACR2A interacts with Vav1, a guanine nucleotide exchange factor, through its proline-rich domain. This interaction is crucial for the recruitment of CRACR2A-containing vesicles to the immunological synapse, facilitating T cell receptor signaling and the activation of downstream pathways such as Ca2+-NFAT and Jnk-AP1 (Srikanth2016A; Srikanth2016Aa).

CRACR2A also functions as a calcium-activated dynein adaptor, interacting with the dynein-dynactin complex. This interaction is calcium-dependent and is important for regulating endocytic traffic and intracellular transport processes (Wang2019CRACR2a).


## References


[1. (Wang2019CRACR2a) Yuxiao Wang, Walter Huynh, Taylor D. Skokan, Wen Lu, Arthur Weiss, and Ronald D. Vale. Cracr2a is a calcium-activated dynein adaptor protein that regulates endocytic traffic. Journal of Cell Biology, 218(5):1619–1633, February 2019. URL: http://dx.doi.org/10.1083/jcb.201806097, doi:10.1083/jcb.201806097. This article has 51 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1083/jcb.201806097)

2. (Wang2022EFCAB4B) EFCAB4B (CRACR2A) genetic variants associated with COVID-19 fatality. This article has 2 citations.

3. (Wang2018A) A new calcium-activated dynein adaptor protein, CRACR2a, regulates clathrin-independent endocytic traffic in T cells. This article has 0 citations.

[4. (Srikanth2016A) Sonal Srikanth, Jin Seok Woo, and Yousang Gwack. A large rab gtpase family in a small gtpase world. Small GTPases, 8(1):43–48, May 2016. URL: http://dx.doi.org/10.1080/21541248.2016.1192921, doi:10.1080/21541248.2016.1192921. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/21541248.2016.1192921)

[5. (Wu2021Biallelic) Beibei Wu, Laura Rice, Jennifer Shrimpton, Dylan Lawless, Kieran Walker, Clive Carter, Lynn McKeown, Rashida Anwar, Gina M Doody, Sonal Srikanth, Yousang Gwack, and Sinisa Savic. Biallelic mutations in calcium release activated channel regulator 2a (cracr2a) cause a primary immunodeficiency disorder. eLife, December 2021. URL: http://dx.doi.org/10.7554/elife.72559, doi:10.7554/elife.72559. This article has 13 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.72559)

[6. (Srikanth2010A) Sonal Srikanth, Hea-Jin Jung, Kyun-Do Kim, Puneet Souda, Julian Whitelegge, and Yousang Gwack. A novel ef-hand protein, cracr2a, is a cytosolic ca2+ sensor that stabilizes crac channels in t cells. Nature Cell Biology, 12(5):436–446, April 2010. URL: http://dx.doi.org/10.1038/ncb2045, doi:10.1038/ncb2045. This article has 197 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncb2045)

[7. (Srikanth2016Aa) Sonal Srikanth, Kyun-Do Kim, Yuanyuan Gao, Jin Seok Woo, Shubhamoy Ghosh, Guillaume Calmettes, Aviv Paz, Jeff Abramson, Meisheng Jiang, and Yousang Gwack. A large rab gtpase encoded by cracr2a is a component of subsynaptic vesicles that transmit t cell activation signals. Science Signaling, March 2016. URL: http://dx.doi.org/10.1126/scisignal.aac9171, doi:10.1126/scisignal.aac9171. This article has 32 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1126/scisignal.aac9171)

[8. (Wilson2015Expression) Lesley A. Wilson, Lynn McKeown, Sarka Tumova, Jing Li, and David J. Beech. Expression of a long variant of cracr2a that belongs to the rab gtpase protein family in endothelial cells. Biochemical and Biophysical Research Communications, 456(1):398–402, January 2015. URL: http://dx.doi.org/10.1016/j.bbrc.2014.11.095, doi:10.1016/j.bbrc.2014.11.095. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2014.11.095)